Pulmonary Fibrosis

About Idiopathic Pulmonary Fibrosis

According to the National Institutes of Health, idiopathic pulmonary fibrosis (IPF) is a condition in which over a period of time the lung tissue becomes thickened, stiff, and scarred. The development of the scar tissue is called fibrosis. As the lung tissue becomes scarred and thicker, the lungs lose their ability to transfer oxygen into the bloodstream. As a result, the brain and other organs don't receive the oxygen they need. In some cases, doctors can determine the cause of the fibrosis, but in most cases, there is not a known cause. When there is no known etiology for the fibrosis (and certain pathologic criteria are met) the disease is called idiopathic pulmonary fibrosis, or IPF. IPF affects approximately 200,000 individuals in the US, and the annual mortality is estimated to be 40,000.

At present there are no FDA-approved medical therapies.

Disclaimer: This website is not intended as an advertisement. Rather, the purpose of this website is to inform the public of concepts and articles for readers to consider for themselves and to discuss with their family and caregivers. In no way should this information be used to diagnose or treat any disease. This can only be done by a qualified medical professional and only after a complete history and physical examination is done and the proper testing is ordered.

Follow Us:

  • Wix Facebook page
  • Wix Twitter page

© 2013 by  Morgan Allen Design Firm

www.madesignfirm.com